eligo-bioscience.com

Eligo Bioscience

Eligo Bioscience's email is contact@eligo-bioscience.com .

Eligobiotics is a developer of antibiotics intended to treat microbiome precision and bacteria-associated diseases. The company's antibiotics combine CRISPR/Cas system with engineered phage capsids, to develop antimicrobials that are used to eradicate resistant pathogens or virulent bacteria within the human microbiome, enabling clients to get next-generation antimicrobials to treat diseases caused by superbugs.
View Top Employees for Eligo Bioscience
img Website eligo-bioscience.com
img Industry Biotechnology
img Location France, Aquitaine, France
img Employees 35
img Founded 2014
img Email contact@eligo-bioscience.com
img Funding 39,806,084 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website eligo-bioscience.com
img Industry Biotechnology
img Location France, Aquitaine, France
img Employees 35
img Founded 2014
img LinkedIn linkedin.com/company/eligo-bioscience
img Email contact@eligo-bioscience.com
img Funding 39,806,084 USD